Pharyngeal Cancer Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Pharyngeal Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 38 trials

Recruiting
Phase 2

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Head and Neck CancerLaryngeal CancerOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins75 enrolled1 locationNCT07209189
Recruiting
Phase 2

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Oropharyngeal CancerThroat CancerHuman Papilloma Virus+2 more
Memorial Sloan Kettering Cancer Center121 enrolled7 locationsNCT05491512
Recruiting
Phase 4

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Nasopharyngeal Cancer Recurrent
Coherus Oncology, Inc.100 enrolled13 locationsNCT06457503
Recruiting

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Cervical CancerOropharyngeal CancerCervical Dysplasia+1 more
The Institute of Molecular and Translational Medicine, Czech Republic480 enrolled1 locationNCT05774561
Recruiting
Not Applicable

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Tongue CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Mucoepidermoid Carcinoma of the Oral Cavity+48 more
Ohio State University Comprehensive Cancer Center600 enrolled1 locationNCT01473784
Recruiting

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Oropharyngeal CancerHPV-Related Carcinoma
H. Lee Moffitt Cancer Center and Research Institute400 enrolled2 locationsNCT06305676
Recruiting
Phase 2

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

Oropharyngeal Cancer
University of Chicago30 enrolled1 locationNCT07290621
Recruiting
Phase 2

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

Oropharyngeal CancerSquamous Cell Carcinoma of the Oropharynx
University of Michigan Rogel Cancer Center150 enrolled1 locationNCT05894083
Recruiting
Phase 1

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Breast CancerTriple-Negative Breast CancerEsophageal Cancer+9 more
SystImmune Inc.470 enrolled39 locationsNCT05983432
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled45 locationsNCT02012699
Recruiting
Phase 2

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

Oropharyngeal CancerHPV
M.D. Anderson Cancer Center20 enrolled1 locationNCT05363709
Recruiting
Phase 3

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

Oropharyngeal Cancer
Canadian Cancer Trials Group510 enrolled33 locationsNCT05451004
Recruiting
Not Applicable

Enhancing Oral Cancer Awareness

PreventionOral CancerOral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer+3 more
Virginia Commonwealth University60 enrolled1 locationNCT06682494
Recruiting
Phase 2Phase 3

Trop2-targeted immunoPET Imaging of Solid Tumors

Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
Phase 2

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

CarcinomaOropharyngeal Cancer
Zachary Zumsteg50 enrolled4 locationsNCT06445114
Recruiting
Phase 2

Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

Nasopharyngeal Cancer
National University Hospital, Singapore50 enrolled1 locationNCT05305131
Recruiting

Liposomal Bupivacaine and Transoral Robotic Surgery

Post Operative PainOropharyngeal CancerDysphagia, Oropharyngeal+1 more
Geisinger Clinic80 enrolled1 locationNCT05862792
Recruiting

The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer

Hypopharyngeal CancerLaryngeal Cancer
Insel Gruppe AG, University Hospital Bern100 enrolled2 locationsNCT05894070
Recruiting

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

Prostate CancerNasopharyngeal CancerOther Cancer
National Cancer Centre, Singapore5,000 enrolled1 locationNCT04340024
Recruiting
Phase 3

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Nasopharyngeal CancerNasopharyngeal Cancinoma (NPC)
Sun Yat-Sen University Cancer Center580 enrolled19 locationsNCT06749899